Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Feasibility and Efficacy of The Balance Program to Reduce the Impact of Pain on Daily Functioning in Pediatric Sickle Cell Disease

NCT04388241 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.

NCT NCT04388241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04388241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Feasibility and Efficacy of The Balance Program to Reduce the Impact of Pain on Daily Functioning in Pediatric Sickle Cell Disease
Lead sponsor
Children's National Research Institute
Phase
Not applicable
Overall status
Completed
Start date
September 23, 2020
Completion date
August 4, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, sickle cell disease